Total Payments
$111,127
2024 Payments
$4,991
Companies
41
Transactions
1,146
Medicare Patients
8,762
Medicare Billing
$994,788
Payment Breakdown by Category
Other$95,839 (86.2%)
Food & Beverage$13,862 (12.5%)
Travel$1,027 (0.9%)
Consulting$300.00 (0.3%)
Education$99.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95,839 | 44 | 86.2% |
| Food and Beverage | $13,862 | 1,096 | 12.5% |
| Travel and Lodging | $1,027 | 4 | 0.9% |
| Consulting Fee | $300.00 | 1 | 0.3% |
| Education | $99.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $70,481 | 241 | $0 (2024) |
| Amgen Inc. | $29,998 | 86 | $0 (2024) |
| Boston Scientific Corporation | $1,993 | 40 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,641 | 242 | $0 (2024) |
| Abbott Laboratories | $1,059 | 180 | $0 (2024) |
| PFIZER INC. | $850.39 | 68 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $743.23 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $474.30 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $437.37 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $411.23 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,991 | 122 | Janssen Pharmaceuticals, Inc ($3,565) |
| 2023 | $2,480 | 185 | Janssen Pharmaceuticals, Inc ($612.45) |
| 2022 | $13,294 | 105 | Janssen Pharmaceuticals, Inc ($11,890) |
| 2021 | $5,257 | 78 | Janssen Pharmaceuticals, Inc ($4,624) |
| 2020 | $5,676 | 56 | Amgen Inc. ($3,827) |
| 2019 | $20,205 | 135 | Janssen Pharmaceuticals, Inc ($10,601) |
| 2018 | $34,396 | 217 | Amgen Inc. ($17,371) |
| 2017 | $24,828 | 248 | Janssen Pharmaceuticals, Inc ($23,055) |
All Payment Transactions
1,146 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/18/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/12/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $133.37 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Genetic Disease | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $27.23 | General |
| Category: Cardiovascular Device | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,262 | 2,981 | $578,274 | $228,269 |
| 2022 | 24 | 2,071 | 3,140 | $666,428 | $270,783 |
| 2021 | 21 | 2,072 | 3,242 | $630,897 | $257,469 |
| 2020 | 24 | 2,357 | 3,618 | $647,808 | $238,267 |
Total Patients
8,762
Total Services
12,981
Medicare Billing
$994,788
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 584 | 1,049 | $223,437 | $92,215 | 41.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 265 | 279 | $116,064 | $40,715 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 268 | 307 | $44,208 | $20,011 | 45.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 26 | 26 | $40,413 | $17,050 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 230 | 247 | $21,489 | $10,723 | 49.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 28 | 28 | $16,252 | $6,047 | 37.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 107 | 109 | $15,243 | $5,687 | 37.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 89 | $12,816 | $5,564 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $17,225 | $5,420 | 31.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $9,720 | $3,700 | 38.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 19 | 19 | $8,816 | $3,285 | 37.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 32 | 45 | $4,361 | $2,537 | 58.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 216 | 242 | $10,242 | $2,512 | 24.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 35 | 37 | $6,660 | $1,968 | 29.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 12 | 44 | $4,444 | $1,604 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,047 | $1,532 | 37.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 37 | 75 | $4,725 | $1,404 | 29.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 28 | 28 | $3,908 | $1,378 | 35.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 39 | 81 | $4,212 | $1,143 | 27.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $2,600 | $851.76 | 32.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 19 | 19 | $2,052 | $757.34 | 36.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 15 | $1,170 | $588.00 | 50.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 23 | 23 | $1,174 | $460.00 | 39.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 22 | 22 | $1,106 | $411.39 | 37.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 19 | 19 | $969.00 | $349.41 | 36.1% |
About Dr. Stephen Algeo, MD
Dr. Stephen Algeo, MD is a Cardiovascular Disease healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487632212.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Algeo, MD has received a total of $111,127 in payments from pharmaceutical and medical device companies, with $4,991 received in 2024. These payments were reported across 1,146 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($95,839).
As a Medicare-enrolled provider, Algeo has provided services to 8,762 Medicare beneficiaries, totaling 12,981 services with total Medicare billing of $994,788. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Tucson, AZ
- Active Since 01/03/2006
- Last Updated 02/01/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1487632212
Products in Payments
- XARELTO (Drug) $70,519
- Repatha (Biological) $29,799
- WATCHMAN (Device) $1,536
- ENTRESTO (Drug) $1,021
- ELIQUIS (Drug) $842.30
- LifeVest (Device) $743.23
- LEQVIO (Drug) $619.47
- VERQUVO (Drug) $330.48
- PRALUENT (Drug) $306.74
- WATCHMAN Access System (Device) $283.62
- UPTRAVI (Drug) $250.03
- JARDIANCE (Drug) $236.63
- BRILINTA (Drug) $221.82
- GALLANT (Device) $210.63
- Vascepa (Drug) $195.09
- Arcalyst (Drug) $191.53
- Pacemakers (Device) $181.53
- PRADAXA (Drug) $171.88
- Corlanor (Drug) $170.69
- VYNDAQEL (Drug) $158.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tucson
Thomas Waggoner, D.o, D.O
Cardiovascular Disease — Payments: $543,824
Cardiovascular Disease $543,824
Marvin Slepian, Md, MD
Cardiovascular Disease — Payments: $280,127
Cardiovascular Disease $280,127
Paul Fenster, Md, MD
Cardiovascular Disease — Payments: $192,170
Cardiovascular Disease $192,170
Karl Kern, Md, MD
Cardiovascular Disease — Payments: $167,139
Cardiovascular Disease $167,139
Kartik Reddy, Md, MD
Cardiovascular Disease — Payments: $81,896
Cardiovascular Disease $81,896
Mark Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $70,960
Cardiovascular Disease $70,960